Abstract
Excessive maternal inflammatory response is involved in the pathogenesis of preeclampsia. Few epidemiologic studies have investigated the associations between genetic variations in the inflammatory mediator genes and preeclampsia risk, and these studies have reached inconsistent results. We examined 31 single-nucleotide polymorphisms in IL-1A, IL-1B, IL-1R1, IL-2RA, IL-5RA, IL-6, IL-6R, TNFSF11, TNFRSF11A, IL-28RA, IRAK4, and KIT genes and the risk of preeclampsia and its clinical subtypes in a nested case-control study including 203 preeclampsia cases and 233 controls. We found that IL-1R1, IL-5RA, IL-6R, and TNFSF11 were associated with the risk of preeclampsia. Although the significant associations observed for preeclampsia overall were mainly seen for late-onset preeclampsia and severe preeclampsia, IL-6R (rs2229238) and TNFSF11 (rs9525643) polymorphisms were associated with the risk of early-onset preeclampsia. TNFSF11 (rs2200287 and rs2148072) polymorphisms were associated with risk of mild preeclampsia. Our study provided the first evidence that genetic variations in inflammatory mediator genes IL-1R1, IL-6R, TNFSF11, and IL-5RA were associated with preeclampsia risk, and the risk varied by preeclampsia subtypes.
Similar content being viewed by others
References
Al-Jameil N, Tabassum H, Al-Mayouf H, Al-Otay L, Al-Shenefy A, Khan F. Identification of predictive marker of prerenal damage in pregnant women with preeclampsia and women at high risk—a prospective study conducted in Riyadh, Saudi Arabia. Int J Med Sci Public Health. 2014;1(1):1.
Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Global Health. 2014; 2(6):e323–e333.
James JL, Whitley GS, Cartwright JE. Pre-eclampsia: fitting together the placental, immune an cardiovascular pieces. J Pathol. 2010;221(4):363–378.
Franchim CS, Sass N, Mattar R, et al. Inflammatory mediators gene polymorphisms in preeclampsia. Hypertens Pregnancy. 2011;30(3):338–346.
Malek A, Sager R, Schneider H. Effect of hypoxia, oxidative stress and lipopolysaccharides on the release of prostaglandins and cytokines from human term placental explants. Placenta. 2001;22(suppl A):S45–S50.
Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta 1. J Clin Endocrinol Metab. 1997;82(5):1582–1588.
Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspect Med. 2007;28(2):192–209.
Ghasemi M, Kashani E, Fayyaz A, Attar M, Shahbazi M. Interleukin-1 alpha variation is associated with the risk of developing preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2015; 193:75–78.
Andraweera PH, Dekker GA, Jayasekara RW, Dissanayake VH, Roberts CT. Polymorphisms in the inflammatory pathway genes and the risk of preeclampsia in Sinhalese women. J Maternal Fetal Neonatal Med. 2016;29(7):1072–1076.
Li J, Liu M, Zong J, et al. Genetic variations in IL1A and IL1RN are associated with the risk of preeclampsia in Chinese Han population. Sci Rep. 2014;4:5250.
Mohajertehran F, Afshari JT, Rezaieyazdi Z, Ghomian N. Association of single nucleotide polymorphisms in the human tumor necrosis factor-a and interleukin 1-b genes in patients with pre-eclampsia. Iran J Allergy Asthma Immunol. 2012;11(3):224–229.
Kang L, Chen CH, Yu CH, Chang CH, Chang FM. Interleukin-1b gene is not associated with preeclampsia in Taiwanese. Taiwan J Obstet Gynecol. 2012;51(2):240–244.
Goddard KA, Tromp G, Romero R, et al. Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum Hered. 2007;63(1):1–16.
Haggerty CL, Ferrell RE, Hubel CA, Markovic N, Harger G, Ness RB. Association between allelic variants in cytokine genes and preeclampsia. Am J Obstet Gynecol. 2005;193(1):209–215.
Hefler LA, Tempfer CB, Gregg AR. Polymorphisms within the interleukin-1b gene cluster and preeclampsia. Obstet Gynecol. 2001;97(5):664–668.
Ohkuchi A, Hirashima C, Matsubara S, et al. Alterations in pla-cental growth factor levels before and after the onset of pree-clampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res. 2007;151(2):151.
Wang Y, Zhao N, Qiu J, et al. Folic acid supplementation and dietary folate intake, and risk of preeclampsia. Eur J Clin Nutr. 2015;69(10):1145–1150.
Chen BE, Sakoda LC, Hsing AW, Rosenberg PS. Resampling-based multiple hypothesis testing procedures for genetic case-control association studies. Genet Epidemiol. 2006;30(6):495–507.
Wang N, Akey JM, Zhang K, Chakraborty R, Jin L. Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Am J Hum Genet. 2002;71(5):1227–1234.
Acuner Ozbabacan SE, Gursoy A, Nussinov R, Keskin O. The structural pathway of interleukin 1 (IL-1) initiated signaling reveals mechanisms of oncogenic mutations and SNPs in inflammation and cancer. PLoS Comput Biol. 2014;10(2):e1003470.
Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–550.
Cartegni L. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acid Res. 2003;31(13):3568–3571.
Raghupathy R. Cytokines as key players in the pathophysiology of preeclampsia. Med Princ Pract. 2013;22(suppl 1):8–19.
Wang Z, Yunis E, De Jo. Santos M, Xiao L, Anderson D, Hill J. T helper 1-type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1B promoter region. Gene Immun. 2002;3(1):38–42.
Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod. 2000;15(3):713–718.
Zhang Z, Gao Y, Zhang L, et al. Alterations of IL-6, IL-6R and gp130 in early and late onset severe preeclampsia. Hypertens Pregnancy. 2013;32(3):270–280.
Pinheiro MB, Gomes KB, Ronda CR, et al. Severe preeclampsia: association of genes polymorphisms and maternal cyto-kines production in Brazilian population. Cytokine. 2015;71(2):232–237.
Valencia Villalvazo EY, Canto-Cetina T, Romero Arauz JF, et al. Analysis of polymorphisms in interleukin-10, interleukin-6, and interleukin-1 receptor antagonist in Mexican-Mestizo women with pre-eclampsia. Genet Test Mol Biomarkers. 2012;16(11):1263–1269.
Vural P, Degirmencioglu S, Saral NY, et al. Tumor necrosis factor alpha, interleukin-6 and interleukin-10 polymorphisms in pree-clampsia. J Obstet Gynaecol Res. 2010;36(1):64–71.
de Lima TH, Sass N, Mattar R, et al. Cytokine gene polymorphisms in preeclampsia and eclampsia. Hypertens Res. 2009;32(7):565–569.
Stonek F, Metzenbauer M, Hafner E, Philipp K, Tempfer C. Interleukin 6-174 G/C promoter polymorphism and pregnancy complications: results of a prospective cohort study in 1626 pregnant women. Am J Reprod Immunol. 2008;59(4):347–351.
Saarela T, Hiltunen M, Helisalmi S, Heinonen S, Laakso M. Polymorphisms of interleukin-6, hepatic lipase and calpain-10 genes, and preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2006;128(1-2):175–179.
Graveley BR. Sorting out the complexity of SR protein functions. RNA. 2000;6(09):1197–1211.
Chen J, Zhang J, Hu H, Jin Y, Xue M. Polymorphisms of RAD50, IL33 and IL1RL1 are associated with atopic asthma in Chinese population. Tissue Antigens. 2015;86(6):443–447.
Darnay BG, Haridas V, Ni J, Moore PA, Aggarwal BB. Characterization of the intracellular domain of receptor activator of NF-κB (RANK) Interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase. J Biol Chem. 1998;273(32):20551–20555.
So T, Lee SW, Croft M. Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Int J Hematol. 2006;83(1):1–11.
Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970–975.
Takatsu K, Kouro T, Nagai Y. Interleukin 5 in the link between the innate and acquired immune response. Adv Immunol. 2009; 101:191–236.
Szabo S, Mody M, Romero R, et al. Activation of villous tropho-blastic p38 and ERK1/2 signaling pathways in preterm preeclamp-sia and HELLP syndrome. Pathol Oncol Res. 2015;21(3):659–668.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Wu, W., Yang, H., Feng, Y. et al. Polymorphisms in Inflammatory Mediator Genes and Risk of Preeclampsia in Taiyuan, China. Reprod. Sci. 24, 539–547 (2017). https://doi.org/10.1177/1933719116660844
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719116660844